The diverse functions of the PD1 inhibitory pathway - PubMed (original) (raw)
Review
. 2018 Mar;18(3):153-167.
doi: 10.1038/nri.2017.108. Epub 2017 Nov 13.
Affiliations
- PMID: 28990585
- DOI: 10.1038/nri.2017.108
Review
The diverse functions of the PD1 inhibitory pathway
Arlene H Sharpe et al. Nat Rev Immunol. 2018 Mar.
Abstract
T cell activation is a highly regulated process involving peptide-MHC engagement of the T cell receptor and positive costimulatory signals. Upon activation, coinhibitory 'checkpoints', including programmed cell death protein 1 (PD1), become induced to regulate T cells. PD1 has an essential role in balancing protective immunity and immunopathology, homeostasis and tolerance. However, during responses to chronic pathogens and tumours, PD1 expression can limit protective immunity. Recently developed PD1 pathway inhibitors have revolutionized cancer treatment for some patients, but the majority of patients do not show complete responses, and adverse events have been noted. This Review discusses the diverse roles of the PD1 pathway in regulating immune responses and how this knowledge can improve cancer immunotherapy as well as restore and/or maintain tolerance during autoimmunity and transplantation.
Similar articles
- An optimized protocol for the in vitro generation and functional analysis of human PD1/PD-L1 signal.
Khedri M, Abnous K, Rafatpanah H, Ramezani M. Khedri M, et al. J Recept Signal Transduct Res. 2018 Feb;38(1):31-36. doi: 10.1080/10799893.2017.1414843. Epub 2017 Dec 18. J Recept Signal Transduct Res. 2018. PMID: 29252078 - Coinhibitory Pathways in Immunotherapy for Cancer.
Baumeister SH, Freeman GJ, Dranoff G, Sharpe AH. Baumeister SH, et al. Annu Rev Immunol. 2016 May 20;34:539-73. doi: 10.1146/annurev-immunol-032414-112049. Epub 2016 Feb 25. Annu Rev Immunol. 2016. PMID: 26927206 Review. - PDL-1/PD1 inhibitors: antibody or antinobody?
Aoun F, Rassy EE, Assi T, Kattan J. Aoun F, et al. Future Oncol. 2017 Aug;13(19):1669-1671. doi: 10.2217/fon-2017-0215. Epub 2017 Aug 23. Future Oncol. 2017. PMID: 28831825 No abstract available. - Immunotherapy for head and neck cancers: an update and future perspectives.
Doescher J, Laban S, Schuler PJ, Brunner C, Hoffmann TK. Doescher J, et al. Immunotherapy. 2019 May;11(7):561-564. doi: 10.2217/imt-2019-0022. Immunotherapy. 2019. PMID: 30943860 Review. No abstract available. - [Immunotherapy in non-small cell lung cancer: inhibition of PD1/PDL1 pathway].
Guilleminault L, Carmier D, Heuzé-Vourc'h N, Diot P, Pichon E. Guilleminault L, et al. Rev Pneumol Clin. 2015 Feb;71(1):44-56. doi: 10.1016/j.pneumo.2014.11.004. Epub 2015 Feb 14. Rev Pneumol Clin. 2015. PMID: 25687821 Review. French.
Cited by
- Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms.
Wu Y, Sun X, Kang K, Yang Y, Li H, Zhao A, Niu T. Wu Y, et al. J Hematol Oncol. 2024 Nov 7;17(1):106. doi: 10.1186/s13045-024-01621-x. J Hematol Oncol. 2024. PMID: 39511607 Review. - Causal relationship between hypothyroidism and ulcerative colitis: a bidirectional Mendelian randomization study.
Yang Y, Li J, Wang X, Ma J. Yang Y, et al. BMC Gastroenterol. 2024 Oct 30;24(1):385. doi: 10.1186/s12876-024-03461-y. BMC Gastroenterol. 2024. PMID: 39478467 Free PMC article. - O-GlcNAcylation of enolase 1 serves as a dual regulator of aerobic glycolysis and immune evasion in colorectal cancer.
Zhu Q, Li J, Sun H, Fan Z, Hu J, Chai S, Lin B, Wu L, Qin W, Wang Y, Hsieh-Wilson LC, Yi W. Zhu Q, et al. Proc Natl Acad Sci U S A. 2024 Oct 29;121(44):e2408354121. doi: 10.1073/pnas.2408354121. Epub 2024 Oct 24. Proc Natl Acad Sci U S A. 2024. PMID: 39446384 - Combination of JAK inhibitor and immune checkpoint inhibitor in clinical trials: a breakthrough.
Dong S, Ma Z. Dong S, et al. Front Immunol. 2024 Oct 4;15:1459777. doi: 10.3389/fimmu.2024.1459777. eCollection 2024. Front Immunol. 2024. PMID: 39430743 Free PMC article. No abstract available. - Myeloid gasdermin D drives early-stage T cell immunity and peripheral inflammation in a mouse model of Alzheimer's disease.
Rui W, Wu Y, Yang Y, Xie W, Qin D, Ming J, Ye Z, Lu L, Zong M, Tang X, Fan L, Li S. Rui W, et al. J Neuroinflammation. 2024 Oct 19;21(1):266. doi: 10.1186/s12974-024-03255-9. J Neuroinflammation. 2024. PMID: 39427168 Free PMC article.
References
- Immunity. 2011 Sep 23;35(3):400-12 - PubMed
- Science. 2001 Jan 12;291(5502):319-22 - PubMed
- J Exp Med. 2012 Dec 17;209(13):2485-99 - PubMed
- Immunity. 2016 Feb 16;44(2):274-86 - PubMed
- Cell. 2015 Sep 10;162(6):1229-41 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials